Table 4

Effect of SGN-CD33A and SGD-1882 on cell cycle in HEL 92.1.7 cells

Treatment and concentration% in phase of cell cycle
G1SG2-M
Untreated 50 32 12 
 0    
Nonbinding ADC (ng/mL)    
 100 50 35 11 
SGN-CD33A (ng/mL)    
 1 44 36 17 
 10 26 36 34 
 100 10 22 57 
SGD-1882 (nM)    
 0.01 45 36 15 
 0.1 26 41 29 
 1 73 
Treatment and concentration% in phase of cell cycle
G1SG2-M
Untreated 50 32 12 
 0    
Nonbinding ADC (ng/mL)    
 100 50 35 11 
SGN-CD33A (ng/mL)    
 1 44 36 17 
 10 26 36 34 
 100 10 22 57 
SGD-1882 (nM)    
 0.01 45 36 15 
 0.1 26 41 29 
 1 73 

HEL 92.1.7 cells were incubated with SGN-CD33A, SGD-1882, or a nonbinding control ADC for 48 hours before BrdU incorporation and processing for flow cytometric analysis. The results shown are representative of data obtained from 3 separate experiments. Nascent DNA synthesis was detected with anti-BrdU, whereas total DNA content was determined with propidium iodide. One hundred nanograms per milliliter SGN-CD33A is the ADC equivalent of 1 nM SGD-1882.

or Create an Account

Close Modal
Close Modal